Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
Bernard GR, Macias WL, Joyce DE, et al. Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis. Critical Care. 2003;7:155–163.
This study finds that drotrecogin alfa (activated) decreases mortality during severe sepsis. In addition, the findings of this study confirm existing figures on the safety and efficacy of this treatment.
|
This item has not yet been rated
|
 |
View article abstract
|
